BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5.62 Cr | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹5.62 Cr |
| Mar2025 | ₹1.06 Cr |
| Mar2024 | ₹-0.85 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹-4.81 Cr |
How is Cash Flow from Financing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.62 Cr | 428.38 | |
| Mar2025 | ₹1.06 Cr | Positive | |
| Mar2024 | ₹-0.85 Cr | Negative | |
| Mar2023 | ₹10 Cr | Positive | |
| Mar2022 | ₹-4.81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,130.5 Cr | 7.1% | 12.2% | 185% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7.1% |
12.2% |
185% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses